📰 Kieranf Docherty News
Kieranf Docherty News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Kieranf Docherty. Real-time updates on events, politics, business and more.
April 3, 2024
Our March 2024 month-in-review in hematology features updates to the anemia pipeline, the latest research in sickle cell disease, and the role of SGLT2 inhibition on hematologic outcomes.
February 3, 2024
Alzheimer's disease (AD) is linked to harmful protein accumulations in the brain, primarily β-amyloid (Aβ) aggregates known as plaques, which are central to the disease's pathology. Entresto (sacubitril/valsartan) is a combined neprilysin inhibitor and angiotensin receptor blocker, approved for the
June 7, 2022
Why have SGLT2-inhibitor clinical benefits in HFrEF trials been evident so soon after the drugs are started? Recent studies shed light on one potential mechanism among what are probably many.